New H5N9 bird flu strain found in California, first case in the US
This H5N9 strain, which was identified earlier this month, is different from the H5N1 strain that had already been documented in multiple cases across the U.S. According to the Centers for Disease Control and Prevention, there have been more than 60 people who have been sickened and one person who was killed by H5N1.
Central Valley dairy farmers concerned with avian flu spread
In a notification, the World Organisation for Animal Health confirmed that the strain detected in Merced County is a new strain in the country. The investigation began on Nov. 23, 2024, and it was confirmed on Jan. 13 that 'this is the first confirmed case of HPAI H5N9 in poultry in the United States.'
The USDA Animal and Plant Health Inspection Service (APHIS), in conjunction with State Animal Health and Wildlife Officials, are conducting comprehensive epidemiological investigations and enhanced surveillance in response to the HPAI related events.
World Organisation for Animal Health
This strain of H5N9 was found in a commercial duck premises in Merced County. The specific location of the facility was not officially released.
The announcement states that control measures have been undertaken in an attempt to contain the virus, including control of movement, surveillance and quarantine. The report from the World Organisation for Animal Health also stated that a total of 118,954 birds were killed in December after state officials quarantined the affected area.
Bird flu is primarily spread by wild birds such as ducks and geese as they migrate. While it is fatal to a variety of animals, those species can generally carry it without getting sick, which offers the virus a chance to mutate and thrive.
The virus can be spread through droppings or any interaction between farm-raised poultry and wild birds. It's also easily tracked into a farm on someone's boots or by vehicle.
Unlike previous outbreaks, the one that began in 2022 didn't die out in high summer temperatures.
The virus found another new host when dairy cattle started getting sick last March. That creates more opportunities for the virus to linger and spread and unlike poultry, cattle aren't slaughtered when they get sick because they rarely die from bird flu.
Nearly all of the people infected with bird flu worked around sick animals. Health officials haven't yet found evidence of the disease spreading from person to person.
The Associated Press contributed to this report.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
13 hours ago
- Newsweek
Trump's Ex-Surgeon General Attacks Vaccine Cuts: 'People Are Going To Die'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump's former Surgeon General Jerome Adams has warned that "people are going to die" if the United States cuts funding for mRNA vaccine development. It comes after Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would terminate 22 Biomedical Advanced Research and Development Authority (BARDA) investments in mRNA vaccine development, representing nearly $500 million in federal funding. He said the decision was taken after reviews showed mRNA vaccines "failed protect effectively against upper respiratory infections like COVID and flu." Newsweek contacted the United States Department of Health and Human Services (HHS) for comment via email outside of regular working hours. Former Surgeon General Jerome Adams speaking at the White House in April 2020. Former Surgeon General Jerome Adams speaking at the White House in April 2020. AP Why It Matters Kennedy has been a longtime vaccine critic, and questioned their effectiveness on numerous occasions. His tenure as the head of HHS has seen top vaccine experts, food safety supervisors and other public-health officials either resign or be ousted. The 22 projects are led by major pharmaceutical companies, including Pfizer and Moderna, and aim to develop vaccines against the flu, COVID-19 and H5N1. mRNA technology, which underpins these vaccines, is widely credited with helping slow the spread of the coronavirus during the 2020 pandemic. Infectious-disease specialists have also warned that future pandemics will be harder to stop without the help of mRNA. What To Know Adams, who served in Trump's first administration, said in an interview with CBS News on Sunday that mRNA technology accelerated vaccine development by an estimated 18 to 24 months. He added that "by the most conservative estimates, at least 2 million lives were saved" during the pandemic because of mRNA vaccines. "It's a natural molecule that's in all of our bodies. It's like a recipe card that tells your body how to make a protein," he said. "And this new idea, again, helps us develop vaccines and new treatments for everything from cancer, melanoma - which my wife has - to HIV, to better flu vaccines." He added: "These are advances that are not going to happen now... people are going to die because we're cutting short funding for this technology." Several other infectious disease experts have also spoken out against Kennedy's decision. Rick Bright, the former director of BARDA, said on X: "A bad day for science, and huge blow to our national security. This decision will have dangerous repercussions." Dr. Thomas A. Russo, an expert in infectious diseases, told Newsweek that Kennedy's decision was "shortsighted," and said mRNA vaccines "will be critical when the next, inevitable infectious diseases crisis rears its ugly head." What People Are Saying RFK Jr. said on X last week: "We reviewed the science, listened to the experts, and acted. BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu." Infectious diseases expert Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, who specializes in pandemic preparedness, told Newsweek: "RFK's actions are completely devoid of value. They are only designed to serve more distrust of a proven and valuable vaccine technology. The repercussions of this decision will serve only to diminish the resiliency of the United States, and the world, to infectious disease threats." What Happens Next In his statement, Kennedy urged the department to shift from mRNA vaccines and "invest in better solutions," but did not specify alternatives. Lawmakers, public-health officials, and industry leaders are expected to press HHS for detailed timelines and alternative research investments options.
Yahoo
5 days ago
- Yahoo
How RFK Jr.'s mRNA crackdown affects vaccine making and future pandemics
The Trump administration's decision to terminate hundreds of millions of dollars to develop mRNA vaccines and treatments imperils the country's ability to fight future pandemics and is built on false or misleading claims about the technology, public health experts said. Vaccine development is typically a years-long process, but mRNA technology paired with massive injections of federal funding during the coronavirus pandemic drastically slashed the timeline. The first covid shots, based on mRNA, were in people's arms less than a year after the United States recorded its first coronavirus case - a signature achievement of the first Trump administration. The flexible technology provided a road map for how to quickly respond to pathogens that are constantly evolving, including H5N1 avian bird flu, a candidate to spark the next pandemic. Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. But research into H5N1 mRNA vaccines were among nearly two dozen mRNA projects supported by the government's biodefense agency that were terminated or altered, according to a Department of Health and Human Services statement released Tuesday. The moves affect $500 million in projects, according to HHS, including covid and flu therapeutics and vaccines. 'This represents a significant setback for our preparedness efforts in responding to infectious-disease outbreaks,' said Dawn O'Connell, the former assistant secretary of preparedness and response at HHS during the Biden administration. If viruses change, mRNA can be quickly rebooted and manufactured. But HHS Secretary Robert F. Kennedy Jr. has criticized mRNA vaccines, arguing that they are ineffective at fighting upper respiratory infections and keeping up with the mutations of a virus. Kennedy has a history of disparaging the mRNA coronavirus vaccines, in 2021 falsely calling them the 'deadliest vaccine ever made.' He has also said there was a 'poison' in it - claims refuted by medical experts. He has also been under pressure from anti-vaccine activists who say he has not done enough to remove mRNA vaccines from the market. The full scope of mRNA projects terminated was not immediately clear. Multiple companies mentioned by HHS did not immediately respond to questions. A spokesman for Moderna, which previously lost funding to develop an mRNA bird flu vaccine, said the company was not aware of new contract cancellations. The AstraZeneca program that HHS is restructuring is an RNA-based pandemic influenza vaccine that is in early stages of development. The company is exploring options for next steps, a spokeswoman said. An inhaled mRNA treatment for flu and covid being developed at Emory University was terminated. Some late-stage projects are proceeding, such as early human testing of an mRNA-based H5N1 candidate being developed by Arcturus Therapeutics 'to preserve prior taxpayer investment,' according to HHS. Gritstone Bio, which HHS said had a project proposal rejected, already ceased operating earlier this year after declaring bankruptcy. A terminated contract to Tiba Biotech was for a H1N1 flu treatment that was not based on mRNA, but a different RNA technology. The company received a stop work order late Tuesday afternoon. 'This comes as a surprise given the Department's stated goal of winding down mRNA vaccine development,' Jasdave Chahal, Tiba's chief scientific officer, said in an email. 'Our project does not involve the development of an mRNA product and is a therapeutic rather than a vaccine.' 'It's going to deter innovations,' said Dorit Reiss, a professor at the University of California College of the Law at San Francisco, whose research focuses on vaccine law and policy. 'Why invest in new technologies if the government can not only refuse to fund them, but if it's going to cancel already promised contracts?' HHS said in its statement that 'other uses of mRNA technology,' such as cancer treatments, are not affected by the announcement. But researchers worried that the Trump administration's criticism of the mRNA technology would have a chilling effect on one of the most promising fields in medicine. In 2023, Katalin Kariko and Drew Weissman shared the Nobel Prize in medicine for fundamental work on mRNA that enabled the development of coronavirus vaccines. 'It's absolutely perplexing why this is happening,' said Jeff Coller, a professor of RNA biology and therapeutics at Johns Hopkins University who has studied mRNA for more than three decades. 'You have to sort of scratch your head to wonder why the secretary is directing these sort of actions against probably one of the most powerful platforms in medicine that has come along in the last 20 years.' Six scientific and medical experts said Kennedy and HHS offered misleading assessments of mRNA technology as they announced the termination of research. Here are the issues they flagged with some of the statements: - - - 'The data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu,' Kennedy said in a statement. It's true that mRNA vaccines can be ineffective at preventing coronavirus infections, although data from the Centers for Disease Control and Prevention shows they still offer some protection. But several scientific experts noted the primary purpose of vaccination is to prevent hospitalizations and death, which the mRNA vaccines have effectively done, according to CDC data. The FDA has not approved an mRNA flu vaccine, so experts said it was premature to make sweeping claims about its potential efficacy. - - - 'One mutation and the vaccine becomes ineffective,' Kennedy said in a video. The coronavirus keeps evolving in a way that makes it easier to infect people who have some immunity from vaccination or prior infection. But medical experts said the mRNA vaccines have been resilient in maintaining protection against severe outcomes. Manufacturers have also been able to update formulas annually to better target new variants. 'That is actually one of the most powerful aspects of mRNA vaccines: that you can, in real time, develop new mRNAs against the virus as the virus changes,' Coller said. 'I'm not sure why that would be considered a bad thing.' - - - 'We've seen now these epidemics of myocarditis,' Kennedy said at a news conference. Coronavirus vaccines designed using mRNA carry a very small risk of myocarditis, which is inflammation of the heart, from the coronavirus vaccine, particularly in young men. However, medical experts said the data shows there is not an 'epidemic' of the condition; in fact, the rates of myocarditis and other heart illness are much higher from the virus instead of the vaccine. Jessica Malaty Rivera, an infectious-disease epidemiologist, said this rhetoric was part of the pandemic revisionist 'revenge tour.' 'Calling it an epidemic is absolutely misleading,' she said. - - - 'Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions – like whole-virus vaccines and novel platforms' - HHS statement Scientific experts said a variety of vaccine types are often required to fight emerging infectious diseases. In some cases, whole-virus vaccines have been known to have serious side effects. Peter Hotez, a physician and co-director of the Texas Children's Hospital Center for Vaccine Development, said he was surprised to hear HHS tout whole-virus vaccines because China had used a whole-virus vaccine for coronavirus that was 'pretty mediocre,' Hotez said. Kennedy is 'pushing a technology that is actually probably the most problematic of all vaccines we could pick,' Hotez said. - - - Rachel Roubein, Sabrina Malhi and Daniel Gilbert contributed to this report Related Content Trump is threatening to take over D.C. Here's what he can and can't do. They once shared recipes. Now her family is going hungry in Gaza. Pets are being abandoned, surrendered amid Trump's immigration crackdown Solve the daily Crossword
Newsweek
5 days ago
- Newsweek
Trump Brushes Off Major Success From First Term: 'Long Time Ago'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. President Donald Trump on Wednesday brushed off what is widely considered to be among the biggest uncontested successes of his first term while reacting to Health and Human Services Secretary Robert F. Kennedy Jr.'s move to pull $500 million in funding for next-generation mRNA-based vaccines to tackle viruses like Covid, H5N1 and the flu. "You were the driving force behind Operation Warp Speed, these mRNA vaccines that are the gold standard," a reporter asked Trump during a White House event on Wednesday. Operation Warp Speed was a 2020 public-private partnership, initiated by the first Trump administration, aimed at accelerating the development and distribution of a COVID-19 vaccine. At the time, it was almost universally accepted that an effective vaccine for the coronavirus was at least 18 months to two years away. Trump's operation did it in less than a year. "Now, your health secretary is pulling back all the funding for research, he's saying that the risks outweigh the benefits, which puts him at odds with the entire medical community, and with you," the reporter continued. "What's going on?" "Research on what?" Trump asked. "Into mRNA vaccines," she clarified. "Well, we're going to look at that," the president replied. "We're talking about it and they're doing a very good job, and you know, that is a pass." Trump went on to briefly acknowledge the success of Operation Warp Speed before dismissing it. "Operation Warp Speed was, whether you're a Republican or Democrat, considered one of the most incredible things ever done in this country," the president said. "The efficiency, the way it was done, the distribution, everything about it has been amazing." Then he added: "But, you know, that was now a long time ago. And we're onto other things, but we are speaking about it. We have meetings about it ... we're looking for other answers to other problems, to other sicknesses and diseases and I think we're doing really well." This is a breaking news story. Updates to follow.
